Neural Regeneration Research · 2019 · 34 citations · 37 references
PharmacyNeurobiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurotoxicologyDrug-induced NeurotoxicityNecrosisNeurodegeneration MechanismsNeuronal Cell DeathNeurotoxic MechanismsNeurotoxicity MechanismsMethamphetamine ToxicityNecroptosis In Neural TissueNecroptotic SignalingNecrotic Neuronal InjuryNeuronal NecrosisNeurotoxic ActionNeurotoxicity Of DrugsWestern Blot Analysis
Methamphetamine is one of the most prevalent drugs abused in the world. Methamphetamine abusers usually present with hyperpyrexia (39°C), hallucination and other psychiatric symptoms. However, the detailed mechanism underlying its neurotoxic action remains elusive. This study investigated the effects of methamphetamine + 39°C on primary cortical neurons from the cortex of embryonic Sprague-Dawley rats. Primary cortex neurons were exposed to 1 mM methamphetamine + 39°C. Propidium iodide staining and lactate dehydrogenase release detection showed that methamphetamine + 39°C triggered obvious necrosis-like death in cultured primary cortical neurons, which could be partially inhibited by receptor-interacting protein-1 (RIP1) inhibitor Necrostatin-1 partially. Western blot assay results showed that there were increases in the expressions of receptor-interacting protein-3 (RIP3) and mixed lineage kinase domain-like protein (MLKL) in the primary cortical neurons treated with 1 mM methamphetamine + 39°C for 3 hours. After pre-treatment with RIP3 inhibitor GSK'872, propidium iodide staining and lactate dehydrogenase release detection showed that neuronal necrosis rate was significantly decreased; RIP3 and MLKL protein expression significantly decreased. Immunohistochemistry staining results also showed that the expressions of RIP3 and MLKL were up-regulated in brain specimens from humans who had died of methamphetamine abuse. Taken together, the above results suggest that methamphetamine + 39°C can induce RIP3/MLKL regulated necroptosis, thereby resulting in neurotoxicity. The study protocol was approved by the Medical Ethics Committee of the Third Xiangya Hospital of Central South University, China (approval numbers: 2017-S026 and 2017-S033) on March 7, 2017.
37
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Pratyusha Mandal, Scott B. Berger, Sirika Pillay et al. · Molecular Cell · 2014 · 615 citations · Full text
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Yasushi Ito, Dimitry Ofengeim, Ayaz Najafov et al. · Science · 2016 · 607 citations · Full text